<DOC>
	<DOCNO>NCT01350869</DOCNO>
	<brief_summary>The objective study evaluate effectiveness safety everolimus-eluting stent ( XIENCE , Abbott ) `` real world '' daily practice compare first-generation drug-eluting stent ( sirolimus-eluting stent ) .</brief_summary>
	<brief_title>Evaluation Everolimus-Eluting Stents ( The K-XIENCE Registry )</brief_title>
	<detailed_description>This study non-randomized , open-label registry compare efficacy safety everolimus-eluting stent versus sirolimus-eluting stent patient coronary artery disease .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>Patients receive XIENCE stent The patient guardian agree study protocol schedule clinical followup , provide informed , write consent , approve appropriate Institutional Review Board/Ethics Committee respective clinical site . Patients mixture DESs Terminal illness life expectancy &lt; 1 year . Patients cardiogenic shock</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>